Skip to main content

Mintz Advises on MoonLake Immunotherapeutics’ $200 Million Public Offering

Mintz advised the underwriters in connection with MoonLake Immunotherapeutics’ $200 million public offering of Class A ordinary shares.

Leerink Partners, Guggenheim Securities, Cantor and LifeSci Capital acted as joint bookrunning managers for the offering. H.C. Wainwright & Co. and Clear Street acted as lead managers for the offering.

The Mintz capital markets team included William Hicks, John Rudy, Nishant Dharia, Jocelyn Sun, and Paty Garza-Gonzalez. Terri Shieh-Newton assisted with intellectual property matters and Joanne Hawana assisted with regulatory matters. Members of the Mintz team are based in the Boston, New York, San Diego, San Francisco and Washington, DC offices.